152 related articles for article (PubMed ID: 24459835)
21. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
[TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
Eser OK; Ergin A; Hasçelik G
Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
[TBL] [Abstract][Full Text] [Related]
23. Tigecycline susceptibility report from an Indian tertiary care hospital.
Behera B; Das A; Mathur P; Kapil A; Gadepalli R; Dhawan B
Indian J Med Res; 2009 Apr; 129(4):446-50. PubMed ID: 19535842
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
Seifert H; Stefanik D; Wisplinghoff H
J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
[No Abstract] [Full Text] [Related]
25. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
[TBL] [Abstract][Full Text] [Related]
26. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
[TBL] [Abstract][Full Text] [Related]
27. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):217-21. PubMed ID: 23522845
[TBL] [Abstract][Full Text] [Related]
28. Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans.
Gajic I; Ranin L; Kekic D; Opavski N; Smitran A; Mijac V; Jovanovic S; Hadnadjev M; Travar M; Mijovic G
Acta Microbiol Immunol Hung; 2020 Mar; 67(3):176-181. PubMed ID: 32160781
[TBL] [Abstract][Full Text] [Related]
29. The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used.
Zárate MS; Serruto G; Smayevsky J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e351-2. PubMed ID: 20031463
[No Abstract] [Full Text] [Related]
30. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
Tiengrim S; Tribuddharat C; Thamlikitkul V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
[TBL] [Abstract][Full Text] [Related]
32. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
Castanheira M; Mendes RE; Jones RN
Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008.
Wang YF; Dowzicky MJ
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):73-9. PubMed ID: 20727474
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of tigecycline and colistin against A. baumannii clinical bloodstream isolates during an 8-year period.
Spiliopoulou A; Jelastopulu E; Vamvakopoulou S; Bartzavali C; Kolonitsiou F; Anastassiou ED; Christofidou M
J Chemother; 2015 Oct; 27(5):266-70. PubMed ID: 24827985
[TBL] [Abstract][Full Text] [Related]
35. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.
Curcio D; Fernández F
J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503
[No Abstract] [Full Text] [Related]
36. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
[TBL] [Abstract][Full Text] [Related]
37. Impact of test methodology, media type and ion content on the susceptibility of Acinetobacter spp. to tigecycline.
Qu J; Zong Z; Yu R; Hu T; Ye H; Lü X
J Antimicrob Chemother; 2014 Jun; 69(6):1710-1. PubMed ID: 24481321
[No Abstract] [Full Text] [Related]
38. Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs.
Gómez-Garcés JL; Aracil B; Gil Y; Burillo A
J Chemother; 2009 Jun; 21(3):267-71. PubMed ID: 19567346
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.
Rizek C; Ferraz JR; van der Heijden IM; Giudice M; Mostachio AK; Paez J; Carrilho C; Levin AS; Costa SF
J Infect Chemother; 2015 Feb; 21(2):114-7. PubMed ID: 25456893
[TBL] [Abstract][Full Text] [Related]
40. Comparative in vitro activity of tigecycline and nine other antibiotics against gram-negative bacterial isolates, including ESBL-producing strains.
Jamal WY; Al Hashem G; Khodakhast F; Rotimi VO
J Chemother; 2009 Jun; 21(3):261-6. PubMed ID: 19567345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
